In the present study, we report that, despite the presence of one perfect p53 consensus sequence homology (designated SCL CS) and four half-sites within the 3'-untranslated region of the stem cell leukemia (SCL) gene, the native endogenous gene is not regulated by p53. We employ a tet-repressible system to show that, under conditions in which the WAF1 mRNA steady-state level is upregulated fourfold by p53, the SCL mRNA level is not altered. In a previous report, we demonstrated that p53 interactions with the SCL CS can upregulate downstream reporter gene activity 43-fold in transient reporter assays. This disparity prompted us to explore the dierences between p53 regulation of SCL CS activity in organized (chromosomally integrated) and disorganized (non-replicating episomal plasmid) chromatin. We show that p53 can increase (between 3 ± 80-fold), decrease (between 5 ± 33-fold) or have no eect upon transactivation of an SCL CS/reporter fusion gene depending upon chromosomal integration site. Most studies used to characterize p53 binding sites employ transient transfection assays. Our results suggest that characterization of consensus sequence homologies by assay of transiently transfected cells may be inaccurate.
In the present study, we report that, despite the presence of one perfect p53 consensus sequence homology (designated SCL CS) and four half-sites within the 3'-untranslated region of the stem cell leukemia (SCL) gene, the native endogenous gene is not regulated by p53. We employ a tet-repressible system to show that, under conditions in which the WAF1 mRNA steady-state level is upregulated fourfold by p53, the SCL mRNA level is not altered. In a previous report, we demonstrated that p53 interactions with the SCL CS can upregulate downstream reporter gene activity 43-fold in transient reporter assays. This disparity prompted us to explore the dierences between p53 regulation of SCL CS activity in organized (chromosomally integrated) and disorganized (non-replicating episomal plasmid) chromatin. We show that p53 can increase (between 3 ± 80-fold),
Introduction
Our previous studies indicate that p53 activation through SCL CS cassettes ligated at variable positions relative to the TATA box in a series of reporter vectors is distance-dependent (Cook et al., 1995) . In transient assays, the SCL CS mediates a 43-fold p53-dependent upregulation of the associated downstream reporter gene when proximal (*100 bp) to the TATA box but only a 3 ± 4-fold activation when ligated 4180 bp from the TATA box. Clearly, in transient reporter assays, distance between a p53 CS homology and the TATA box can in¯uence p53-mediated regulation of gene expression.
While the SCL CS and half-sites, within the native gene, lie at a distance from the TATA box that would suggest that they might not be functional, clearly many investigators attribute distal (4500 bp from the TATA box) CS homologies with p53 regulatory regulatory eects. Most of the reports which conclude that speci®c CS homologies regulate nearby genes are based upon transient assays using reporter constructs. In such studies, the arti®cial constructs are often not designed to preserve the native relationships of CS homologies to TATA boxes or to downstream coding regions. Furthermore, these experiments typically employ transient transfections where the plasmids remain episomal while, in fact, relationships between upstream and downstream transcriptional regulatory elements may vary with integration into organized chromatin. However, one compelling study employing genomic footprinting provides evidence that p53 binds in vivo to the CS homologies associated with the WAF1 and GADD45 genes following irradiation (Chin et al., 1997) . The relevant WAF1 CS homologies lie at distances of 1.3 and 2.2 kbp upstream of the TATA box while the relevant GADD45 footprint lies at 1.6 kbp downstream of the major transcription start site (within the third intron). In the same study, no DNase I footprints were observed for the CS homology which lies within intron 1 of the MDM2 gene and is postulated to mediate induction by p53 (Zauberman et al., 1995) .
The in vivo footprint study suggests that CS homologies located at a distance from the TATA box may still bind DNA and (presumably) transactivate nearby genes. Our earlier studies show that the SCL CS and WAF1 CS both have no transcriptional augmentation activity, in transient assays, when located 1.7 kbp downstream from the TATA box in a reporter vector (Cook et al., 1995) . This prompted us to ask whether results from transient assays parallel those in vivo. p53 might interact dierently with p53 consensus sequence homologies present in organized chromatin compared to those present in episomal plasmids.
In order to explore this idea, we prepared p53 tetracycline-repressible (tet-repressible) cell lines from a p53-null line and assayed for p53-regulation of endogenous SCL gene expression. While WAF1 steady-state RNA was upregulated fourfold by a 20-fold induction of p53, the SCL mRNA was not aected. The SCL gene appears not to be transcriptionally regulated by p53 under these conditions.
We further tested the eects of chromosomal integration upon the SCL CS by establishing stable transfectants of the reporter vector used in previous transient assays. Using the same reporter vector in which p53 was found to elevate transcription 43-fold in transient assays, p53 can (1) repress, (2) elevate or (3) have no eect upon transcription in assays of chromosomally integrated vector. Dierent clones demonstrate dierent characteristics dependent, apparently, upon integration site.
A number of reports (Raycroft et al., 1991; Santhanam et al., 1991; Farmer et al., 1992; Mack et al., 1993; Osifchin et al., 1994; Park et al., 1994; Raimond et al., 1995; O'Conner et al., 1995; Morris et al., 1996; and Metcalf et al., 1997 , to name but a few) have been published in which p53 binding sites have been studied by transient cotransfection of consensus sequence/reporter gene or promoter/reporter gene constructs with p53 expression plasmids. These studies have prompted deductions regarding the relative activities of wild-type and mutant forms of p53 as transcriptional activators. Our data suggest that characterization of consensus sequence homologies by assay of transiently transfected cells may be inaccurate.
Results

SCL CS and p53 half-site homologies
In addition to the p53 DNA-binding CS homology, SCL CS, we have identi®ed four p53 CS half-sites which reside in the 3'-untranslated region of the SCL gene ( Figure 1 ). Three of these motifs possess sequences of AGACTTGCCT, tGGCTTGTCC and AGACTTGCCa and lie 2039 bp, 1075 bp and 676 bp upstream of the SCL CS. The fourth is of sequence AGACTTGCCC and is positioned 398 bp downstream of the SCL CS. Figure 1a illustrates the SCL cDNA and indicates the positions of p53-CS homologies and the identi®ed translocation breakpoint (Begley et al., 1989) . Figure 1b presents the nucleotide sequences and positions of the p53 CS homology and half-sites.
Transient transfections of K562/pUHD10-3/p53 clones 1 ± 4 K562-Ad cells (p53-null, human chronic myelogenous leukemia) were stably transfected with pUHD10-3/p53 and the tTA-encoding pUHD15-1neo in order to generate clones in which p53 is induced in the absence of tet. pUHD10-3/p53 is an expression construct regulated by a tet-repressible transcriptional regulatory element and encoding p53. pUHD15-1neo is a second expression construct encoding a positive transactivator of the tet operator (tTA) and the neomycin phosphotransferase selectable marker product (Gossen and Bujard, 1992; Furth et al., 1994; Howe et al., 1995; Ackland-Berglund and Leib, 1995) . Four clones with G418 resistance were examined for tet-mediated dierential p53 activity by transient transfection with a p53 consensus sequence homology-regulated luciferase reporter plasmid (SCL CS(1)/ T81luc, Figure 2 ) and a chloramphenicol acetyltransferase (CAT) internal control (pRAScat). Clones 1 ± 4 are activated 71-, 64-, 19-and 44-fold, respectively, in the absence of tet (Figure 3a ). Dierences may re¯ect dierent levels of expression of p53 secondary to integration site or copy number of p53-encoding plasmid or the tTA-encoding plasmid. We chose clone 1 (henceforth called K562-Ad/pUHD10-3/p53, clone 1), which demonstrates the greatest dierential activity (in the presence or absence of tet) for further experimentation.
Western blot and detection of p53 protein in K562-Ad/pUHD10-3/p53 clone 1 Figure 3b shows that tet represses p53 production 19-fold in K562-Ad/pUHD10-3/p53 clone 1. In two separate experiments with clone 1, tet repressed p53 expression 20.1-and 17.4-fold, respectively. Clearly p53 continues to be expressed in the presence of tet but at a much lower level.
Northern blot analyses of RNAs from K562-Ad/pUHD10-3/p53 clone 1
In order to determine whether the endogenous SCL gene in K562 cells can be regulated by p53, we examined mRNA isolated from K562-Ad/pUHD10-3/ p53 clone 1 after treatment with tet or vehicle for 48 h. p53 activates expression of the control WAF1 gene expression fourfold but has no eect upon SCL or b-actin (Figure 4 ). The endogenous SCL gene does not appear to be transcriptionally regulated by p53 (under conditions which alter WAF1 mRNA accumulation). Stable transfection of K562/pUHD10-3/p53 clone 1 Clone 1 was further stably transfected with SCL CS(1)/ T81luc and pCEP4 (encodes hygromycin phosphotransferase). Ten clones were selected with resistance to hygromycin (200 mg/ml). These were referred to as SS1-SS10 (SS is an acronym for stable/stable). Clones were examined in the presence and absence of tet in order to assess the eects of p53 upon the integrated SCL p53 CS homology (Figure 5a) . Three of the clones (SS3, SS7 and SS9) possess no luciferase activity. In clones SS2, SS4, SS8 and SS10, p53 activates transcription from the integrated SCL site. In clones SS1, SS5 and SS6, p53 represses transcription of luciferase. Activation varies between 3 ± 80-fold. Repression varies between 5 ± 33-fold.
Since it was possible that the clones which exhibited no luciferase activity (SS3, SS7 and SS9), might possess only integrated pCEP4 (no luciferase plasmid), we performed a Southern blot to con®rm the presence of the integrated reporter vector. Genomic DNA from K562-Ad cells was spiked with DNA at the cellular equivalent of one to ®ve copies as a control for luciferase reporter vector transgene copy number and compared with clones 1 ± 10 ( Figure 5b ). By densitometric analyses, clones 1, 3, 4, 8 and 9 possess one copy, clones 2, 5, 6 and 10 possess two copies, and clone 7 has three copies of SCL CS(1)/T81luc. There appears to be no relationship between reporter gene copy number and either basal or p53-inducible levels of expression.
Transient transfections of SS clones
SS Clones 1 ± 10 were all derived from K562-Ad/ pUHD10-3/p53 clone 1 (a clone which initially (7) of tetracycline. The primary antibody is Ab-2 which reacts with human wild-type p53. The four lanes represent material from four dierent protein preparations Figure 4 Northern blot of total RNA derived from K562-Ad/ pUHD10-3/p53 clone 1 cultured in the presence or absence of tet. The same blot was probed sequentially with WAF1, SCL and b-actin sequences. Positions of the major non-polyadenylated transcripts are indicated (28S, 4.7 kb; 18S, 1.9 kb; 5S, 120 nt). The 7SL transcript is also apparent on one blot because the SCL probe (derived from the 3'-UT region of the gene) possesses an S-family Alu which cross-hybridizes with 7SL RNA demonstrated excellent dierential p53 regulation by tet). Since the 10 SS clones exhibit vastly dierent properties, we transiently transfected each of these to show that tTA and p53 were still being properly expressed and regulated ( Figure 6 ). We transfected each clone with SCL CS/HOCAT (Figure 2 ) and assayed at 48 h for CAT expression (with or without tet). All ten clones demonstrate dramatically increased expression in the presence of p53. Even clones SS3, SS7 and SS9, which possess no detectable luciferase activity in the presence or absence of tet, clearly dierentially express p53. We conclude that in each of these clones, the SCLCS(1)/T81luc plasmid integrated into chromatin regions where it could not be activated.
SS1, SS2, SS6 and SS10 were also transiently transfected with the control plasmid HOCAT (which possesses no p53 binding site, Figure 2 ). Each clone demonstrates a level of CAT activity that is independent of tet-treatment ( Figure 6 ). Tet-repressible activity is clearly dependent upon presence of the SCL CS within the transfected plasmids.
Discussion
While there is decisive evidence that p53 binds tightly to DNA consensus sequence homologies and can mediate transcriptional activation of downstream genes in arti®cial situations, the evidence for in vivo physiological gene regulation by p53-CS interactions is limited. The evidence is largely based upon transient reporter assay data and, therefore, is of a deductive nature. El-Deiry et al. (1993) reported that the WAF1 gene is regulated by p53 through a p53 binding site located 2.4 kbp upstream of the TATA. Transient transfections of luciferase reporter constructs were performed in a dexamethasone-inducible p53 system. Luciferase activity was greatly reduced in the absence of dexamethasone when the relevant CS homology was included in the reporter construct, hence the authors concluded that p53 regulation of WAF1 occurs through this CS homology. Deb et al. (1994) reported that wildtype p53 transactivates the human EGF receptor promoter implicating p53 in control of cellular proliferation. A region between 715 and 7569 possesses three motifs with 90 ± 100% identity to the p53 CS. In transient transfections performed in p53-null Saos-2 cells with and without a co-transfected wild-type p53 expression plasmid, this region was found to transactivate CAT. Jackson and Yardley (1997) reported that proximal (781 to 7177) and distal (73133 to 73182) elements of the MCK (muscle-speci®c creatinine kinases) gene cooperate to permit high level synergistic activation by p53. In these experiments, transient transfections of promoter/CAT reporter constructs with p53 expression plasmid were performed in CV1 cells. Expression of CAT was p53-regulated when the proximal and distal elements were present (in their wild-type relative con®guration). Deletion of either the upstream or downstream elements greatly compromised activity. More recently, Jackson et al. (1998) observed, using electron microscopy of plasmid DNA, that p53 tetramers can physically link the proximal and distal sites, a possible mechanism for synergy.
At the start of this study, there were no reports, to our collective knowledge, in which p53-CS interactions within 3'-untranslated regions of genes conferred p53-regulation. There was also no evidence to the contrary. In the present study, we show that the endogenous SCL gene is not regulated by p53 despite the presence of one perfect p53 CS homology and three half-sites within the 3'-untranslated region and despite the fact that the SCL CS can confer a 43-fold p53-mediated upregulation of a reporter gene in transient transfection assays. We suggest that the reasons for this could be (1) eects of distance from the upstream core promoter and/or (2) repressive eects of surrounding chromatin.
Consensus sequence homologies have been shown to respond in a dose-dependent manner to p53. The PCNA promoter possesses a CS homology at 7217 to 7236. Transient co-transfection of a PCNA promoter/ CAT construct and wild-type p53 construct into p53-null Saos-2 cells demonstrates that low concentrations of p53 activate and high concentrations inhibit CAT activity (Morris et al., 1996) . In a similar study, Kristjuhand and Maimets (1995) show that p53 activates at low doses and represses at high doses the DNA binding site, CON (Funk et al., 1992) . in transient transfection studies. However, the repression of expression that we see in clones SS1, SS5 and SS6 is clearly not related to p53 concentration (which should be virtually identical in SS1-SS10).
Investigators have shown that other promoters and promoter elements may be subject to eects of nucleoprotein complexes. Pennie et al. (1995) cotransfected a transient reporter plasmid (assumes a disorganized chromatin pattern) with a replicating template (assumes a highly ordered chromatin structure) and reported that cAMP treatment has opposite eects upon the MMTV LTR within the two types of templates, increasing transcription from the transiently transfected template but antagonizing transcription from the stably replicating template.
In conclusion, in vivo site-directed mutagenesis may be the most convincing (though technically rigorous) method available to demonstrate that p53 interactions with putative p53-binding sites actually regulate nearby genes.
Materials and methods
Generation of adherent K562 subline
K562 cells (ATCC CCL 243, human chronic myelogenous leukemia) are p53-null cells (Bi et al., 1994) which possess primarily suspension characteristics, but 10 ± 20% adhere to disposable plasticware surfaces (Sarstedt, Newton, NC, USA). Suspension K562 cells were maintained and passaged for several months on Sarstedt plastic in order to select a population with increased adherence. In the resulting subline (K562-Ad), as many as 90% of the cells adhere to plasticware when grown from 20 ± 90% conuence in a single dish or¯ask. Cells are trypsinized using trypsin-EDTA (GibcoBRL, Grand Island, NY, USA) solution brie¯y and sparingly.
Generation of plasmids
Descriptions of the methods used to generate SCL CS(1)/ T81luc, HOCAT, SCL CS/HOCAT and pRAScat are given in Cook et al. (1995) . pUHD10-3 and tTAneo were obtained from Hermann Bujard (Gossen and Bujard, 1992) . p53 cDNA was obtained by digestion of pHp53B (a cDNA in pBR322, American Type Culture Collection 57254) with BamHI and ligation into BamHI-digested pUHD10-3. The resulting plasmid is referred to as pUHD10-3/p53.
Generation of K562-Ad clones stably transfected with a p53-inducible plasmid K562-Ad p53-null cells were plated at 1610 6 /100-mm dish on four dishes. Two dishes were transfected with 5 mg of pUHD10-3/p53 (control). Two dishes were transfected with 5 mg of pUHD10-3/p53 and 5 mg of pUHD15-1neo (experimental) using 50 mg of lipofectin per dish. Cells were treated with G418 (Geneticin, GibcoBRL, Grand Island, NY, USA) in fully supplemented media at concentrations of 200 and 400 mg/ml starting 72 h post- transfection. Four clones were selected possessing resistance to 400 mg/ml of G418.
Transient transfectionof K562-Ad/pUHD10-3/p53 clones 1 ± 4
Cells were washed twice in 50 ml of serum-free, tet-free medium (to remove residual tet) and plated 24 h prior to transfection. For each clone, three 60 mm dishes were plated at 70% con¯uence in the presence of tet (2 mg/ml) and three in the absence of tet. Cells were transiently transfected with 5 mg of SCL CS(1)/T81luc (in the presence of tet where appropriate) and 0.5 mg of pRAScat internal control using lipofectin (25 mg/60-mm dish). Appropriate cells were maintained from the initial plating to time of harvest with tet. Cells were harvested 48 h after transfection and assayed for luciferase and CAT activity. Luciferase values were normalized for variability in transfection eciency and cell number using CAT values. The experiment was performed three times.
Western blot and detection of p53 protein in K562-Ad/pUHD10-3/p53 clone 1 Protein aliquots obtained from whole cell extracts (cell cultured with and without tet) were electrophoresed on a 10% polyacrylamide denaturing gel (10 mg/well). Gels were blotted to Hybond ECL nitrocellulose, and p53 Ab-2 (Oncogene Science Inc., Cambridge, MA, USA) and the ECL Western Blotting kit (Amersham Life Science, Arlington Heights, IL, USA) were used to detect p53 protein. The Rainbow 2 colored protein markers from Amersham were used as protein molecular weight standards.
Northern blot analyses of RNAs from K562-Ad/pUHD10-3/p53 clone 1 Clone 1 cells were incubated in the absence of tet or in the presence of 2 mg/ml tet for 48 h. RNAs were harvested by the method of Chomczynski and Sacchi (1987) . 10 mg of each RNA was electrophoresed on a denaturing agarose gel and transferred to Zeta-Probe blotting membrane (BioRad Laboratories, Hercules, CA, USA). The membrane was sequentially probed with sequences from human WAF1 (a 1 kbp EcoRI/XhoI fragment from ATCC 79928), human SCL (a 2.3 kbp EcoRI fragment consisting of the entire 3'-untranslated region of the SCL gene, obtained from Dr Ilan Kirsch, NCI, Bethesda, MD, USA), human b-actin (a 2 kbp BamHI fragment, Ponte et al., 1984) . cDNA inserts were gel-eluted and radiolabeled using Prime-It II from Stratagene (La Jolla, CA, USA). Filters were hybridized with 1 ± 2610 6 c.p.m./ml (*1610 9 c.p.m./ mg).
Stable transfection of K562/pUHD10-3/p53 clone 1 Clone 1, which demonstrates excellent p53-inducible activity was stably transfected with SCL CS(1)/T81Luc and pCEP4. Speci®cally, cells were plated in 60-mm dishes and transfected with (control) 5 mg of SCL CS(1)T81luc or (experimental) 5 mg of SCL CS(1)/T81luc and 0.5 mg of pCEP4 (encodes hygromycin resistance, Invitrogen, Carlsbad, CA, USA) and 25 mg of lipofectin. All cells were maintained consistently with tet (2 mg/ml) and G418 (400 mg/ml). Cells were selected with hygromycin (200 mg/ ml). Ten clones were obtained with resistance to hygromycin. Luciferase values were normalized for variability in transfection eciency and cell number using protein values (Biorad Laboratories, Hercules, CA, USA). The experiment was performed three times.
Southern blot
An EcoRI/HincII double digest was performed using genomic DNA derived from control cells (no transgene), control cells spiked with cDNA at the equivalent of one to ®ve copies per cell, and clones 1 ± 10. DNA was electrophoresed on a 1% agarose gel and transferred to Zeta-Probe membrane (Bio-Rad Laboratories, Richmond, CA, USA). EcoRI/HincII were also used to digest the SCL CS(1)T81luc plasmid to liberate a 715 bp luciferase fragment which was gel puri®ed and labeled by random priming using the Prime-It II kit from Stratagene (La Jolla, CA, USA). This probe was used to screen the membrane at 1610 6 c.p.m./ml, *1610 9 c.p.m./mg. Hybridization and wash conditions were according to the recommendations of Bio-Rad and are included with membrane purchase. Copy number was determined by densitometry using an IS-1000 Digital Imaging System from Alpha Innotech Corp. (San Leandro, CA, USA).
Transient transfection of SS clones
Cells were washed twice in 50 ml of serum-free, tet-free medium (to remove residual tet) and plated 24 h prior to transfection. For SS clones 1 ± 10, three 60-mm dishes were plated at 70% con¯uence in the presence of tet (2 mg/ml) and three in the absence of tet. Cells were transiently transfected with 5 mg of SCL CS/HOCAT (in the presence of tet where appropriate) using lipofectin (25 mg/60-mm dish). As controls, clones SS1, SS2, SS6 and SS10 were transiently transfected with 5 mg of HOCAT, with and without tet, using lipofectin. For both experiments, appropriate cells were maintained from the initial plating to time of harvest with tet. Cells were harvested 48 h after transfection and assayed for CAT activity and protein. CAT values were normalized for variability in transfection eciency and cell number using protein values.
Statistics
Luciferase activity dierences were statistically analysed using ANOVA followed by a Bonferroni Multiple Comparisons post hoc test.
